These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 1677911

  • 1. Rationale for large scale bone marrow hemopoietic stem cell manipulation.
    Menichella G, Pierelli L, Vittori M, Paoloni A, Foddai ML, Serafini R, Iacone A, Mango G.
    Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911
    [Abstract] [Full Text] [Related]

  • 2. A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent.
    Montuoro A, De Rosa L, Del Monte C, Blandino F, Pandolfi A, Lanti T, De Laurenzi A.
    Haematologica; 1991 Mar; 76 Suppl 1():7-9. PubMed ID: 1713876
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The blood bank as a source of hematopoietic stem cells.
    Lasky LC.
    Prog Clin Biol Res; 1986 Mar; 211():199-225. PubMed ID: 3515360
    [No Abstract] [Full Text] [Related]

  • 5. Semiautomated autologous bone marrow processing for transplantation.
    Pierelli L, Menichella G, Paoloni A, Serafini R, Vittori M, Foddai ML, Meoni F, Rossi PL, Leone G, Mango G.
    Haematologica; 1991 Mar; 76 Suppl 1():10-1. PubMed ID: 1677909
    [Abstract] [Full Text] [Related]

  • 6. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 7. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD, Liang PS, Ulz L.
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [Abstract] [Full Text] [Related]

  • 8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 9. Red cell salvage and reinfusion in pediatric bone marrow donors.
    Kletzel M, Olszewski M, Danner-Koptik K, Coyne K, Haut P.
    Bone Marrow Transplant; 1999 Aug; 24(4):385-8. PubMed ID: 10467327
    [Abstract] [Full Text] [Related]

  • 10. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.
    Koh MB, Prentice HG, Lowdell MW.
    Bone Marrow Transplant; 1999 May; 23(10):1071-9. PubMed ID: 10373075
    [Abstract] [Full Text] [Related]

  • 11. Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow.
    Schanz U, Gmür J.
    Bone Marrow Transplant; 1992 Dec; 10(6):507-13. PubMed ID: 1490200
    [Abstract] [Full Text] [Related]

  • 12. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P, Flesch M.
    Nouv Rev Fr Hematol (1978); 1986 Dec; 28(2):97-105. PubMed ID: 2942838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE.
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [Abstract] [Full Text] [Related]

  • 17. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 19. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra.
    Soydan E, Ayyildiz E, Dalva K, Topçuoğlu P, Tol M, Arslan O, Ilhan O, Arat M.
    Transfus Apher Sci; 2007 Jun; 36(3):269-73. PubMed ID: 17574924
    [Abstract] [Full Text] [Related]

  • 20. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ, Sackstein R.
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.